A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for<i> Clostridium difficile</i> Infection in Immunocompromised Patients

We found evidence that supports the use of FMT for treatment of CD infection in immunocompromised patients, with similar rates of serious adverse events to immunocompetent patients.